Gulfo Adele M. 4
4 · NewAmsterdam Pharma Co N.V. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Gulfo Adele M.
Director
Transactions
- Award
Ordinary Shares
2026-01-07+3,400→ 14,260 total - Award
Option (right to buy)
2026-01-07+15,300→ 15,300 totalExercise: $35.45Exp: 2036-01-07→ Ordinary Shares (15,300 underlying)
Footnotes (3)
- [F1]Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. All of the RSUs will vest on the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date.
- [F2]Each RSU was granted on January 7, 2026 for no consideration.
- [F3]All of the ordinary shares underlying the option will vest on January 2, 2027, the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date.